"We have made four deals through Pharmalicensing" Fabienne Roussel, University of Liège

By profiling with Pharmalicensing, the University of Liège (ULg) has made a number of development deals and has obtained the contact details of many new potential partners.

The French-speaking Belgium-based University has almost 20 licensing opportunities listed on the Pharmalicensing website. These originate from its eight faculties, which cover Medicine, Veterinary Medicine, Sciences and Applied Sciences.

In this case study Fabienne Roussel, Technology Transfer Officer at the University of Liège, speaks about Pharmalicensing’s reach to the global community and how the service has helped them accelerate some of the University’s product developments. Ms Roussel is based at the Interface Entreprises-Université which is responsible for the University of Liège's technology transfers (including IP protection and licensing)

The flexibility in posting opportunities stands out as the major highlight for the University of Liège; Pharmalicensing allows Universities and non-profit organizations to post an unlimited number of opportunities on its website. Current opportunities from ULg include, among other technologies, a new aerosol treatment for asthma, a new composition for the prevention/treatment of atherosclerosis and a new method for sensitive environmental, human and agro-food diagnostic.

In the five years that the University has been registered with Pharmalicensing, it has signed four deals with other pharmaceutical partners, one of which was a pre-licensing agreement and three of which were licensing agreements. Therapeutically, one agreement was in the urinary health area; one was an antibody development deal and the other the development of a new therapeutic approach to type I diabetes.

‘The return’ is the difference

"The difference between Pharmalicensing and other partnering companies is the return we get in response to our licensing opportunities" explained Ms Roussel. "We use two partnering resources and we get better feedback from Pharmalicensing. The website gives us a great opportunity to show what we have to offer"

The technology transfer office updates its pages on Pharmalicensing monthly and in addition to the opportunities, finds the reports and website information useful to keep up with the industry. The group has also found some of the Partneringdesk deals reports interesting to assess current dealmaking trends.

Both Ms Roussel and the University of Liège hope Pharmalicensing will continue to generate contacts for its technologies and remain as ‘a great website to post licensing opportunities for the industry’

See the University of Liège, Interface Entreprises-Université profile

See licensing opportunities from the University of Liège

To make any comments on this article, or to ask a question of the author, please contact the publisher. If you would like to submit an article, please contact the editors.

The opinions expressed in the articles published in this section do not necessarily reflect those of Pharmalicensing or UTEK Corporation. No actions including proposals to or agreements with other companies should be taken by any reader without obtaining specific business or legal advice. Neither the publisher nor the authors accept any liability for any actions or activities undertaken by any reader or other third party as a consequence of these articles or for any errors or omissions therein.